Annual EBITDA:
$60.41M+$13.17M(+27.89%)Summary
- As of today, LGND annual EBITDA is $60.41 million, with the most recent change of +$13.17 million (+27.89%) on December 31, 2024.
- During the last 3 years, LGND annual EBITDA has fallen by -$47.18 million (-43.85%).
- LGND annual EBITDA is now -66.52% below its all-time high of $180.42 million, reached on December 31, 2018.
Performance
LGND EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$62.85M+$44.19M(+236.90%)Summary
- As of today, LGND quarterly EBITDA is $62.85 million, with the most recent change of +$44.19 million (+236.90%) on September 30, 2025.
- Over the past year, LGND quarterly EBITDA has increased by +$42.32 million (+206.24%).
- LGND quarterly EBITDA is now -14.47% below its all-time high of $73.48 million, reached on June 30, 2018.
Performance
LGND Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$65.09M+$42.32M(+185.93%)Summary
- As of today, LGND TTM EBITDA is $65.09 million, with the most recent change of +$42.32 million (+185.93%) on September 30, 2025.
- Over the past year, LGND TTM EBITDA has increased by +$9.51 million (+17.12%).
- LGND TTM EBITDA is now -63.74% below its all-time high of $179.52 million, reached on December 31, 2018.
Performance
LGND TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LGND EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +27.9% | +206.2% | +17.1% |
| 3Y3 Years | -43.9% | +130.0% | -29.8% |
| 5Y5 Years | +58.9% | +657.6% | +57.2% |
LGND EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -43.9% | +27.9% | at high | +330.1% | -29.8% | +212.1% |
| 5Y | 5-Year | -43.9% | +64.6% | at high | +330.1% | -29.8% | +212.1% |
| All-Time | All-Time | -66.5% | +192.5% | -14.5% | +237.2% | -63.7% | +190.7% |
LGND EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $62.85M(+236.9%) | $65.09M(+185.9%) |
| Jun 2025 | - | $18.65M(+168.3%) | $22.76M(+9.1%) |
| Mar 2025 | - | -$27.32M(-350.5%) | $20.86M(-65.5%) |
| Dec 2024 | $60.41M(+27.9%) | $10.90M(-46.9%) | $60.41M(+8.7%) |
| Sep 2024 | - | $20.52M(+22.5%) | $55.57M(+23.8%) |
| Jun 2024 | - | $16.75M(+36.9%) | $44.88M(+25.9%) |
| Mar 2024 | - | $12.23M(+101.4%) | $35.66M(-24.4%) |
| Dec 2023 | $47.23M(-16.0%) | $6.07M(-38.2%) | $47.20M(+51.7%) |
| Sep 2023 | - | $9.83M(+30.6%) | $31.11M(-36.0%) |
| Jun 2023 | - | $7.53M(-68.3%) | $48.60M(-24.5%) |
| Mar 2023 | - | $23.77M(+337.2%) | $64.39M(+11.2%) |
| Dec 2022 | $56.23M(-47.7%) | -$10.02M(-136.7%) | $57.89M(-37.5%) |
| Sep 2022 | - | $27.33M(+17.2%) | $92.67M(+3.1%) |
| Jun 2022 | - | $23.31M(+35.0%) | $89.86M(-0.7%) |
| Mar 2022 | - | $17.27M(-30.3%) | $90.48M(-0.6%) |
| Dec 2021 | $107.59M(+193.2%) | $24.76M(+1.0%) | $91.02M(+23.8%) |
| Sep 2021 | - | $24.52M(+2.5%) | $73.55M(+28.3%) |
| Jun 2021 | - | $23.93M(+34.4%) | $57.32M(+29.2%) |
| Mar 2021 | - | $17.81M(+144.4%) | $44.37M(+20.4%) |
| Dec 2020 | $36.70M(-3.5%) | $7.29M(-12.2%) | $36.84M(-11.0%) |
| Sep 2020 | - | $8.29M(-24.4%) | $41.41M(+30.5%) |
| Jun 2020 | - | $10.97M(+6.8%) | $31.73M(+56.1%) |
| Mar 2020 | - | $10.28M(-13.3%) | $20.32M(-29.6%) |
| Dec 2019 | $38.01M(-78.9%) | $11.86M(+959.8%) | $28.88M(-46.2%) |
| Sep 2019 | - | -$1.38M(-217.0%) | $53.65M(-36.2%) |
| Jun 2019 | - | -$435.00K(-102.3%) | $84.12M(-46.8%) |
| Mar 2019 | - | $18.83M(-48.6%) | $158.03M(-12.0%) |
| Dec 2018 | $180.42M(+123.9%) | $36.63M(+25.9%) | $179.52M(+2.4%) |
| Sep 2018 | - | $29.09M(-60.4%) | $175.23M(+6.0%) |
| Jun 2018 | - | $73.48M(+82.2%) | $165.34M(+53.7%) |
| Mar 2018 | - | $40.32M(+24.7%) | $107.58M(+33.7%) |
| Dec 2017 | $80.60M(+43.4%) | $32.34M(+68.5%) | $80.46M(+14.0%) |
| Sep 2017 | - | $19.20M(+22.1%) | $70.61M(+17.6%) |
| Jun 2017 | - | $15.72M(+19.1%) | $60.05M(+16.6%) |
| Mar 2017 | - | $13.20M(-41.3%) | $51.49M(-8.4%) |
| Dec 2016 | $56.21M(+81.5%) | $22.49M(+160.2%) | $56.21M(+23.1%) |
| Sep 2016 | - | $8.64M(+20.8%) | $45.65M(-2.0%) |
| Jun 2016 | - | $7.16M(-60.1%) | $46.59M(+4.3%) |
| Mar 2016 | - | $17.91M(+50.1%) | $44.66M(+44.2%) |
| Dec 2015 | $30.98M(+32.6%) | $11.94M(+24.5%) | $30.97M(+3.6%) |
| Sep 2015 | - | $9.59M(+83.3%) | $29.89M(+21.1%) |
| Jun 2015 | - | $5.23M(+23.9%) | $24.68M(+14.2%) |
| Mar 2015 | - | $4.22M(-61.1%) | $21.62M(-7.5%) |
| Dec 2014 | $23.37M(+25.3%) | $10.86M(+148.2%) | $23.37M(+18.1%) |
| Sep 2014 | - | $4.38M(+102.3%) | $19.79M(+2.1%) |
| Jun 2014 | - | $2.16M(-63.8%) | $19.38M(-2.7%) |
| Mar 2014 | - | $5.97M(-18.0%) | $19.93M(+6.9%) |
| Dec 2013 | $18.65M(+415.7%) | $7.28M(+83.7%) | $18.64M(+11.9%) |
| Sep 2013 | - | $3.96M(+46.5%) | $16.66M(+38.9%) |
| Jun 2013 | - | $2.71M(-42.3%) | $12.00M(+41.7%) |
| Mar 2013 | - | $4.69M(-11.4%) | $8.47M(+134.2%) |
| Dec 2012 | $3.62M(+36.5%) | $5.30M(+857.8%) | $3.62M(-18.9%) |
| Sep 2012 | - | -$699.00K(+14.9%) | $4.46M(-1.2%) |
| Jun 2012 | - | -$821.00K(-409.9%) | $4.51M(-7.3%) |
| Mar 2012 | - | -$161.00K(-102.6%) | $4.87M(+37.8%) |
| Dec 2011 | $2.65M(+129.0%) | $6.14M(+1051.9%) | $3.53M(+168.0%) |
| Sep 2011 | - | -$645.00K(-38.1%) | -$5.19M(-27.1%) |
| Jun 2011 | - | -$467.00K(+68.8%) | -$4.09M(+41.4%) |
| Mar 2011 | - | -$1.50M(+42.2%) | -$6.97M(+16.3%) |
| Dec 2010 | -$9.15M(+29.7%) | -$2.59M(-659.7%) | -$8.33M(-123.4%) |
| Sep 2010 | - | $462.00K(+113.8%) | -$3.73M(+54.4%) |
| Jun 2010 | - | -$3.35M(-17.4%) | -$8.17M(+4.9%) |
| Mar 2010 | - | -$2.85M(-241.7%) | -$8.59M(+31.6%) |
| Dec 2009 | -$13.01M | $2.02M(+150.7%) | -$12.57M(+22.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$3.98M(-5.4%) | -$16.22M(+13.8%) |
| Jun 2009 | - | -$3.77M(+44.7%) | -$18.82M(+10.0%) |
| Mar 2009 | - | -$6.83M(-315.8%) | -$20.92M(+17.9%) |
| Dec 2008 | -$25.99M(+50.3%) | -$1.64M(+75.0%) | -$25.49M(+20.4%) |
| Sep 2008 | - | -$6.58M(-12.0%) | -$32.02M(+2.3%) |
| Jun 2008 | - | -$5.87M(+48.4%) | -$32.77M(+20.7%) |
| Mar 2008 | - | -$11.39M(-39.5%) | -$41.30M(+22.1%) |
| Dec 2007 | -$52.32M(-146.5%) | -$8.17M(-11.4%) | -$53.04M(-14.8%) |
| Sep 2007 | - | -$7.33M(+49.1%) | -$46.20M(+0.3%) |
| Jun 2007 | - | -$14.41M(+37.7%) | -$46.36M(-19.0%) |
| Mar 2007 | - | -$23.13M(-1636.4%) | -$38.97M(-151.2%) |
| Dec 2006 | -$21.23M(-141.2%) | -$1.33M(+82.2%) | -$15.51M(-39.5%) |
| Sep 2006 | - | -$7.49M(-6.6%) | -$11.12M(-362.5%) |
| Jun 2006 | - | -$7.02M(-2273.4%) | -$2.40M(-184.9%) |
| Mar 2006 | - | $323.00K(-89.4%) | $2.83M(+132.2%) |
| Dec 2005 | -$8.80M(+61.8%) | $3.06M(+148.4%) | -$8.80M(-206.3%) |
| Sep 2005 | - | $1.23M(+169.1%) | $8.28M(+276.4%) |
| Jun 2005 | - | -$1.78M(+84.2%) | -$4.69M(+74.5%) |
| Mar 2005 | - | -$11.31M(-156.2%) | -$18.38M(+17.7%) |
| Dec 2004 | -$23.07M(-300.1%) | $20.14M(+271.6%) | -$22.35M(+21.6%) |
| Sep 2004 | - | -$11.74M(+24.2%) | -$28.49M(-31.6%) |
| Jun 2004 | - | -$15.48M(-1.3%) | -$21.64M(-81.8%) |
| Mar 2004 | - | -$15.27M(-209.1%) | -$11.91M(-106.6%) |
| Dec 2003 | -$5.77M(+65.9%) | $14.00M(+386.1%) | -$5.76M(+71.9%) |
| Sep 2003 | - | -$4.89M(+14.8%) | -$20.50M(+5.1%) |
| Jun 2003 | - | -$5.74M(+37.1%) | -$21.60M(+8.5%) |
| Mar 2003 | - | -$9.13M(-1137.1%) | -$23.62M(-55.3%) |
| Dec 2002 | -$16.92M(-2.1%) | -$738.00K(+87.7%) | -$15.21M(+3.0%) |
| Sep 2002 | - | -$5.99M(+22.7%) | -$15.69M(-25.1%) |
| Jun 2002 | - | -$7.76M(-972.8%) | -$12.54M(-18.1%) |
| Mar 2002 | - | -$723.00K(+40.5%) | -$10.62M(+35.9%) |
| Dec 2001 | -$16.56M(+57.4%) | -$1.22M(+57.3%) | -$16.56M(+29.1%) |
| Sep 2001 | - | -$2.85M(+51.1%) | -$23.37M(+23.9%) |
| Jun 2001 | - | -$5.83M(+12.6%) | -$30.70M(+16.4%) |
| Mar 2001 | - | -$6.67M(+16.9%) | -$36.74M(+5.6%) |
| Dec 2000 | -$38.91M(+21.2%) | -$8.03M(+21.1%) | -$38.91M(+4.7%) |
| Sep 2000 | - | -$10.17M(+14.3%) | -$40.81M(+7.6%) |
| Jun 2000 | - | -$11.87M(-34.2%) | -$44.18M(+6.4%) |
| Mar 2000 | - | -$8.84M(+11.0%) | -$47.23M(+4.4%) |
| Dec 1999 | -$49.38M(+24.4%) | -$9.93M(+26.6%) | -$49.39M(-53.2%) |
| Sep 1999 | - | -$13.54M(+9.2%) | -$32.23M(+50.0%) |
| Jun 1999 | - | -$14.91M(-35.6%) | -$64.49M(+0.4%) |
| Mar 1999 | - | -$11.00M(-252.3%) | -$64.75M(+0.9%) |
| Dec 1998 | -$65.31M(-144.6%) | $7.22M(+115.8%) | -$65.31M(+9.0%) |
| Sep 1998 | - | -$45.80M(-201.8%) | -$71.73M(-112.7%) |
| Jun 1998 | - | -$15.17M(-31.3%) | -$33.73M(-31.5%) |
| Mar 1998 | - | -$11.56M(-1544.6%) | -$25.66M(-22.8%) |
| Dec 1997 | -$26.70M(+7.9%) | $800.00K(+110.3%) | -$20.90M(+29.9%) |
| Sep 1997 | - | -$7.80M(-9.9%) | -$29.80M(-22.1%) |
| Jun 1997 | - | -$7.10M(-4.4%) | -$24.40M(+2.4%) |
| Mar 1997 | - | -$6.80M(+16.0%) | -$25.00M(-7.8%) |
| Dec 1996 | -$28.98M(-28.1%) | -$8.10M(-237.5%) | -$23.20M(-8.9%) |
| Sep 1996 | - | -$2.40M(+68.8%) | -$21.30M(+17.1%) |
| Jun 1996 | - | -$7.70M(-54.0%) | -$25.70M(-104.0%) |
| Mar 1996 | - | -$5.00M(+19.4%) | -$12.60M(-14.5%) |
| Dec 1995 | -$22.61M(-17.1%) | -$6.20M(+8.8%) | -$11.00M(-34.1%) |
| Sep 1995 | - | -$6.80M(-225.9%) | -$8.20M(-41.4%) |
| Jun 1995 | - | $5.40M(+258.8%) | -$5.80M(+65.1%) |
| Mar 1995 | - | -$3.40M(0.0%) | -$16.60M(+9.8%) |
| Dec 1994 | -$19.32M(-49.0%) | -$3.40M(+22.7%) | -$18.40M(-22.7%) |
| Sep 1994 | - | -$4.40M(+18.5%) | -$15.00M(-41.5%) |
| Jun 1994 | - | -$5.40M(-3.8%) | -$10.60M(-103.8%) |
| Mar 1994 | - | -$5.20M | -$5.20M |
| Dec 1993 | -$12.96M(-11.5%) | - | - |
| Dec 1992 | -$11.63M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual EBITDA?
- What is the all-time high annual EBITDA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual EBITDA year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly EBITDA year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM EBITDA?
- What is the all-time high TTM EBITDA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM EBITDA year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual EBITDA?
The current annual EBITDA of LGND is $60.41M
What is the all-time high annual EBITDA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual EBITDA is $180.42M
What is Ligand Pharmaceuticals Incorporated annual EBITDA year-on-year change?
Over the past year, LGND annual EBITDA has changed by +$13.17M (+27.89%)
What is Ligand Pharmaceuticals Incorporated quarterly EBITDA?
The current quarterly EBITDA of LGND is $62.85M
What is the all-time high quarterly EBITDA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly EBITDA is $73.48M
What is Ligand Pharmaceuticals Incorporated quarterly EBITDA year-on-year change?
Over the past year, LGND quarterly EBITDA has changed by +$42.32M (+206.24%)
What is Ligand Pharmaceuticals Incorporated TTM EBITDA?
The current TTM EBITDA of LGND is $65.09M
What is the all-time high TTM EBITDA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM EBITDA is $179.52M
What is Ligand Pharmaceuticals Incorporated TTM EBITDA year-on-year change?
Over the past year, LGND TTM EBITDA has changed by +$9.51M (+17.12%)